Skip to main content
Top
Published in: Pain and Therapy 1/2020

Open Access 01-06-2020 | Neuropathic Pain | Review

Pathophysiologic Approach to Pain Therapy for Complex Pain Entities: A Narrative Review

Authors: Martina Rekatsina, Antonella Paladini, Alba Piroli, Panagiotis Zis, Joseph V. Pergolizzi, Giustino Varrassi

Published in: Pain and Therapy | Issue 1/2020

Login to get access

Abstract

Pain management is challenging for both clinicians and patients. In fact, pain patients are frequently undertreated or even completely untreated. Optimal treatment is based on targeting the underlying mechanisms of pain and tailoring the management modality for each patient using a personalized approach. This narrative review deals with pain conditions that have a complex underlying mechanism and need an individualized and frequently multifactorial approach to pain management. The research is based on previously conducted studies, and does not contain any studies with human participants or animals performed by any of the authors. This is not an exhaustive review of the current evidence. However, it provides the clinician with a perspective on pain therapy targeting the underlying pain mechanism(s). When dealing with complex pain conditions, the prudent physician benefits from having a deep knowledge of various underlying pain mechanisms in order to provide a plan for optimal pharmacological pain relief to patients.
Literature
1.
go back to reference Del Giorno R, Frumento P, Varrassi G, Paladini A, Coaccioli S. Assessment of chronic pain and access to pain therapy: a cross-sectional population-based study. J Pain Res. 2017;10:2577–84.PubMedPubMedCentralCrossRef Del Giorno R, Frumento P, Varrassi G, Paladini A, Coaccioli S. Assessment of chronic pain and access to pain therapy: a cross-sectional population-based study. J Pain Res. 2017;10:2577–84.PubMedPubMedCentralCrossRef
2.
go back to reference Merskey H, Bogduk N. Classification of Chronic Pain. Seattle: IASP Press; 1994. Merskey H, Bogduk N. Classification of Chronic Pain. Seattle: IASP Press; 1994.
3.
go back to reference Kosek E, Cohen M, Baron R, Gebhart GF, Mico JA, Rice AS, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382–6.PubMedCrossRef Kosek E, Cohen M, Baron R, Gebhart GF, Mico JA, Rice AS, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382–6.PubMedCrossRef
4.
go back to reference Nicholas M, Vlaeyen JWS, Rief W, Barke A, Aziz Q, Benoliel R, et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019;160(1):28–37.PubMedCrossRef Nicholas M, Vlaeyen JWS, Rief W, Barke A, Aziz Q, Benoliel R, et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019;160(1):28–37.PubMedCrossRef
5.
go back to reference Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. A classification of chronic pain for ICD-11. Pain. 2015;156(6):1003–7.PubMedPubMedCentral Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. A classification of chronic pain for ICD-11. Pain. 2015;156(6):1003–7.PubMedPubMedCentral
9.
go back to reference Varrassi G, Collett B, Morlion B, et al. Proceedings of the CHANGE PAIN Expert Summit in Rome, June 2010. Curr Med Res Opin. 2011;27:2061–2.PubMedCrossRef Varrassi G, Collett B, Morlion B, et al. Proceedings of the CHANGE PAIN Expert Summit in Rome, June 2010. Curr Med Res Opin. 2011;27:2061–2.PubMedCrossRef
10.
go back to reference Muller-Schwefe G, Jaksch W, Morlion B, Kalso E, Schafer M, Coluzzi F, et al. Make a change: optimising communication and pain management decisions. Curr Med Res Opin. 2011;27(2):481–8.PubMedCrossRef Muller-Schwefe G, Jaksch W, Morlion B, Kalso E, Schafer M, Coluzzi F, et al. Make a change: optimising communication and pain management decisions. Curr Med Res Opin. 2011;27(2):481–8.PubMedCrossRef
11.
go back to reference Varrassi G, Muller-Schwefe G, Pergolizzi J, et al. Pharmacological treatment of chronic pain the need for change. Curr Med Res Opin. 2010;26(5):1231–45.PubMedCrossRef Varrassi G, Muller-Schwefe G, Pergolizzi J, et al. Pharmacological treatment of chronic pain the need for change. Curr Med Res Opin. 2010;26(5):1231–45.PubMedCrossRef
13.
go back to reference Varrassi G, Fusco M, Coaccioli S, Paladini A. Chronic pain and neurodegenerative processes in elderly people. Pain Pract. 2015;15(1):1–3.PubMedCrossRef Varrassi G, Fusco M, Coaccioli S, Paladini A. Chronic pain and neurodegenerative processes in elderly people. Pain Pract. 2015;15(1):1–3.PubMedCrossRef
15.
go back to reference Paladini A, Fusco M, Coaccioli S, Skaper S, Varrassi G. Chronic pain in the elderly: the case for new therapeutic strategies. Pain Physician. 2015;18:E863–E876876.PubMed Paladini A, Fusco M, Coaccioli S, Skaper S, Varrassi G. Chronic pain in the elderly: the case for new therapeutic strategies. Pain Physician. 2015;18:E863–E876876.PubMed
16.
go back to reference Paladini A, Fusco M, Cenacchi T, Schievano C, Piroli A, Varrassi G. Palmitoylethanolamide, a special food for medical purposes, in the treatment of chronic pain: a pooled data meta-analysis. Pain Physician. 2016;19(2):11–24PubMed Paladini A, Fusco M, Cenacchi T, Schievano C, Piroli A, Varrassi G. Palmitoylethanolamide, a special food for medical purposes, in the treatment of chronic pain: a pooled data meta-analysis. Pain Physician. 2016;19(2):11–24PubMed
17.
go back to reference Pergolizzi J, Ahlbeck K, Aldington D, Alon E, Coluzzi F, Dahan A, et al. The development of chronic pain: physiological change necessitates a multidisciplinary approach to treatment. Curr Med Res Opin. 2013;29(9):1127–35.PubMedPubMedCentralCrossRef Pergolizzi J, Ahlbeck K, Aldington D, Alon E, Coluzzi F, Dahan A, et al. The development of chronic pain: physiological change necessitates a multidisciplinary approach to treatment. Curr Med Res Opin. 2013;29(9):1127–35.PubMedPubMedCentralCrossRef
18.
go back to reference Mannion RJ, Woolf CJ. Pain mechanisms and management: a central perspective. Clin J Pain. 2000;16(3 Suppl):S144–S156156.PubMedCrossRef Mannion RJ, Woolf CJ. Pain mechanisms and management: a central perspective. Clin J Pain. 2000;16(3 Suppl):S144–S156156.PubMedCrossRef
19.
go back to reference Larssen M. Ionotropic glutamate receptors in spinal nociceptive processing. Mol Neurobiol. 2009;40:260–88.CrossRef Larssen M. Ionotropic glutamate receptors in spinal nociceptive processing. Mol Neurobiol. 2009;40:260–88.CrossRef
20.
go back to reference Pedersen JL, Andersen OK, Arendt-Nielsen L, Kehlet H. Hyperalgesia and temporal summation of pain after heat injury in man. Pain. 1998;74(2–3):189–97.PubMedCrossRef Pedersen JL, Andersen OK, Arendt-Nielsen L, Kehlet H. Hyperalgesia and temporal summation of pain after heat injury in man. Pain. 1998;74(2–3):189–97.PubMedCrossRef
21.
go back to reference Guirimand F, Dupont X, Brasseur L, Chauvin M, Bouhassira D. The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive flexion reflex and pain in humans. Anesth Analg. 2000;90(2):408–14.PubMed Guirimand F, Dupont X, Brasseur L, Chauvin M, Bouhassira D. The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive flexion reflex and pain in humans. Anesth Analg. 2000;90(2):408–14.PubMed
22.
go back to reference Noppers I, Niesters M, Aarts L, Smith T, Sarton E, Dahan A. Ketamine for the treatment of chronic non-cancer pain. Exp Opin Pharmacother. 2010;11(14):2417–29.CrossRef Noppers I, Niesters M, Aarts L, Smith T, Sarton E, Dahan A. Ketamine for the treatment of chronic non-cancer pain. Exp Opin Pharmacother. 2010;11(14):2417–29.CrossRef
23.
go back to reference Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med (Malden, Mass). 2004;5(3):263–75.CrossRef Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med (Malden, Mass). 2004;5(3):263–75.CrossRef
24.
go back to reference Song GH, Venkatraman V, Ho KY, Chee MW, Yeoh KG, Wilder-Smith CH. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain. 2006;126(1–3):79–90.PubMedCrossRef Song GH, Venkatraman V, Ho KY, Chee MW, Yeoh KG, Wilder-Smith CH. Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls. Pain. 2006;126(1–3):79–90.PubMedCrossRef
25.
go back to reference Pertovaara A, Almeida A. Descending inhibitory systems. In: Cervero F, Jensen T, editors. Handbook of clinical neurology. Amsterdan: Elsevier; 2006. p. 179–192. Pertovaara A, Almeida A. Descending inhibitory systems. In: Cervero F, Jensen T, editors. Handbook of clinical neurology. Amsterdan: Elsevier; 2006. p. 179–192.
26.
go back to reference Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Int Med. 2004;140(6):441–51.PubMedCrossRef Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Int Med. 2004;140(6):441–51.PubMedCrossRef
27.
go back to reference Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9(8):807–19.PubMedCrossRef Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9(8):807–19.PubMedCrossRef
28.
go back to reference Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–73.PubMedPubMedCentralCrossRef Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–73.PubMedPubMedCentralCrossRef
30.
31.
go back to reference Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;96:399–409. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;96:399–409.
33.
go back to reference McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2013;11:3013–25. McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2013;11:3013–25.
35.
go back to reference Vranken JH. Elucidation of pathophysiology and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem. 2012;12(4):304–14.PubMedCrossRef Vranken JH. Elucidation of pathophysiology and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem. 2012;12(4):304–14.PubMedCrossRef
36.
go back to reference Guetti C, Angeletti C, Marinangeli F, Ciccozzi A, Baldascino G, Paladini A, et al. Transdermal buprenorphine for central neuropathic pain: clinical reports. Pain Pract. 2011;11(5):446–52.PubMedCrossRef Guetti C, Angeletti C, Marinangeli F, Ciccozzi A, Baldascino G, Paladini A, et al. Transdermal buprenorphine for central neuropathic pain: clinical reports. Pain Pract. 2011;11(5):446–52.PubMedCrossRef
38.
go back to reference Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010;23(5):611–5.PubMedCrossRef Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010;23(5):611–5.PubMedCrossRef
39.
go back to reference Hauser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, et al. Fibromyalgia. Nat Rev Dis Primers. 2015;1:15022.PubMedCrossRef Hauser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, et al. Fibromyalgia. Nat Rev Dis Primers. 2015;1:15022.PubMedCrossRef
40.
41.
go back to reference Uceyler N, Zeller D, Kahn AK, Kewenig S, Kittel-Schneider S, Schmid A, et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain. 2013;136(Pt 6):1857–67.PubMedCrossRef Uceyler N, Zeller D, Kahn AK, Kewenig S, Kittel-Schneider S, Schmid A, et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain. 2013;136(Pt 6):1857–67.PubMedCrossRef
42.
go back to reference Staud R. Peripheral pain mechanisms in chronic widespread pain. Best Pract Res Clin Rheuamtol. 2011;25(2):155–64.CrossRef Staud R. Peripheral pain mechanisms in chronic widespread pain. Best Pract Res Clin Rheuamtol. 2011;25(2):155–64.CrossRef
43.
go back to reference Calandre EP, Hidalgo J, Rico-Villademoros F. Use of ziprasidone in patients with fibromyalgia: a case series. Rheumatol Int. 2007;27(5):473–6.PubMedCrossRef Calandre EP, Hidalgo J, Rico-Villademoros F. Use of ziprasidone in patients with fibromyalgia: a case series. Rheumatol Int. 2007;27(5):473–6.PubMedCrossRef
44.
go back to reference Perrot S. Fibromyalgia: a misconnection in a multiconnected world? Eur J Pain. 2019;23(5):866–73.PubMedCrossRef Perrot S. Fibromyalgia: a misconnection in a multiconnected world? Eur J Pain. 2019;23(5):866–73.PubMedCrossRef
45.
go back to reference Atzeni F, Gerardi MC, Masala IF, Alciati A, Batticciotto A, Sarzi-Puttini P. An update on emerging drugs for fibromyalgia treatment. Exp Opin Emerg Drugs. 2017;22(4):357–67.CrossRef Atzeni F, Gerardi MC, Masala IF, Alciati A, Batticciotto A, Sarzi-Puttini P. An update on emerging drugs for fibromyalgia treatment. Exp Opin Emerg Drugs. 2017;22(4):357–67.CrossRef
46.
go back to reference Macfarlane GJ, Kronisch C, Atzeni F, Hauser W, Choy EH, Amris K, et al. EULAR recommendations for management of fibromyalgia. Ann Rheum Dis. 2017;76(12):e54.PubMedCrossRef Macfarlane GJ, Kronisch C, Atzeni F, Hauser W, Choy EH, Amris K, et al. EULAR recommendations for management of fibromyalgia. Ann Rheum Dis. 2017;76(12):e54.PubMedCrossRef
47.
go back to reference Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Hauser W, Fluss E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318–28.CrossRefPubMed Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Hauser W, Fluss E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318–28.CrossRefPubMed
48.
go back to reference Del Giorno R, Skaper S, Paladini A, Varrassi G, Coaccioli S. Palmitoylethanolamide in fibromyalgia: results from prospective and retrospective observational studies. Pain Ther. 2015;4(2):169–78.PubMedPubMedCentralCrossRef Del Giorno R, Skaper S, Paladini A, Varrassi G, Coaccioli S. Palmitoylethanolamide in fibromyalgia: results from prospective and retrospective observational studies. Pain Ther. 2015;4(2):169–78.PubMedPubMedCentralCrossRef
49.
go back to reference Angeletti C, Guetti C, Piroli A, Angeletti PM, Paladini A, Ciccozzi A, et al. Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia. Pain Pract. 2013;13(8):657–62.PubMedCrossRef Angeletti C, Guetti C, Piroli A, Angeletti PM, Paladini A, Ciccozzi A, et al. Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia. Pain Pract. 2013;13(8):657–62.PubMedCrossRef
50.
go back to reference Galvani C, Caramaschi P, Mura P, Paladini A, Piroli A, Arnaudo E, et al. Postural counseling represents a novel option in pain management of fibromyalgia patients. J Pain Res. 2019;12:327–37.PubMedPubMedCentralCrossRef Galvani C, Caramaschi P, Mura P, Paladini A, Piroli A, Arnaudo E, et al. Postural counseling represents a novel option in pain management of fibromyalgia patients. J Pain Res. 2019;12:327–37.PubMedPubMedCentralCrossRef
51.
go back to reference Sadeghi M, Erickson A, Castro J, Deiteren A, Harrington AM, Grundy L, et al. Contribution of membrane receptor signalling to chronic visceral pain. Int J Biochem Cell Biol. 2018;98:10–23.PubMedCrossRef Sadeghi M, Erickson A, Castro J, Deiteren A, Harrington AM, Grundy L, et al. Contribution of membrane receptor signalling to chronic visceral pain. Int J Biochem Cell Biol. 2018;98:10–23.PubMedCrossRef
52.
go back to reference Radovanovic-Dinic B, Tesic-Rajkovic S, Grgov S, Petrovic G, Zivkovic V. Irritable bowel syndrome from etiopathogenesis to therapy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018;162(1):1–9.PubMedCrossRef Radovanovic-Dinic B, Tesic-Rajkovic S, Grgov S, Petrovic G, Zivkovic V. Irritable bowel syndrome from etiopathogenesis to therapy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018;162(1):1–9.PubMedCrossRef
53.
go back to reference Kim JS. Pharmacological management of central post-stroke pain: a practical guide. CNS Drugs. 2014;28(9):787–97.PubMedCrossRef Kim JS. Pharmacological management of central post-stroke pain: a practical guide. CNS Drugs. 2014;28(9):787–97.PubMedCrossRef
55.
go back to reference Birklein F, Schlereth T. Complex regional pain syndrome-significant progress in understanding. Pain. 2015;156(Suppl 1):S94–103.PubMedCrossRef Birklein F, Schlereth T. Complex regional pain syndrome-significant progress in understanding. Pain. 2015;156(Suppl 1):S94–103.PubMedCrossRef
56.
go back to reference Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijlstra FJ. Evidence for local inflammation in complex regional pain syndrome type 1. Mediat Inflamm. 2002;11(1):47–51.CrossRef Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijlstra FJ. Evidence for local inflammation in complex regional pain syndrome type 1. Mediat Inflamm. 2002;11(1):47–51.CrossRef
57.
go back to reference Alexander GM, Peterlin BL, Perreault MJ, Grothusen JR, Schwartzman RJ. Changes in plasma cytokines and their soluble receptors in complex regional pain syndrome. J Pain. 2012;13(1):10–20.PubMedCrossRef Alexander GM, Peterlin BL, Perreault MJ, Grothusen JR, Schwartzman RJ. Changes in plasma cytokines and their soluble receptors in complex regional pain syndrome. J Pain. 2012;13(1):10–20.PubMedCrossRef
58.
go back to reference Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 2004;361(1–3):184–7.PubMedCrossRef Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 2004;361(1–3):184–7.PubMedCrossRef
59.
go back to reference Blaes F, Schmitz K, Tschernatsch M, Kaps M, Krasenbrink I, Hempelmann G, et al. Autoimmune etiology of complex regional pain syndrome (M. Sudeck). Neurology. 2004;63(9):1734–6.PubMedCrossRef Blaes F, Schmitz K, Tschernatsch M, Kaps M, Krasenbrink I, Hempelmann G, et al. Autoimmune etiology of complex regional pain syndrome (M. Sudeck). Neurology. 2004;63(9):1734–6.PubMedCrossRef
60.
go back to reference Oaklander AL, Fields HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol. 2009;65(6):629–38.PubMedCrossRef Oaklander AL, Fields HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol. 2009;65(6):629–38.PubMedCrossRef
61.
go back to reference Urits I, Burshtein A, Sharma M, Testa L, Gold PA, Orhurhu V, et al. Low back pain, a comprehensive review: pathophysiology, diagnosis, and treatment. Curr Pain Headache Rep. 2019;23(3):23.PubMedCrossRef Urits I, Burshtein A, Sharma M, Testa L, Gold PA, Orhurhu V, et al. Low back pain, a comprehensive review: pathophysiology, diagnosis, and treatment. Curr Pain Headache Rep. 2019;23(3):23.PubMedCrossRef
63.
go back to reference Partanen JV, Ojala TA, Arokoski JP. Myofascial syndrome and pain: a neurophysiological approach. Pathophysiology. 2010;17(1):19–28.PubMedCrossRef Partanen JV, Ojala TA, Arokoski JP. Myofascial syndrome and pain: a neurophysiological approach. Pathophysiology. 2010;17(1):19–28.PubMedCrossRef
64.
go back to reference Kalichman L, Hunter DJ. Lumbar facet joint osteoarthritis: a review. Semin Arthritis Rheum. 2007;37(2):69–80.PubMedCrossRef Kalichman L, Hunter DJ. Lumbar facet joint osteoarthritis: a review. Semin Arthritis Rheum. 2007;37(2):69–80.PubMedCrossRef
65.
go back to reference Bogduk N. Evidence-informed management of chronic low back pain with facet injections and radiofrequency neurotomy. Spine J. 2008;8(1):56–64.PubMedCrossRef Bogduk N. Evidence-informed management of chronic low back pain with facet injections and radiofrequency neurotomy. Spine J. 2008;8(1):56–64.PubMedCrossRef
66.
go back to reference Comer C, Conaghan PG. Tackling persistent low back pain in primary care. Practitioner. 2009;253(1721):32–4.PubMed Comer C, Conaghan PG. Tackling persistent low back pain in primary care. Practitioner. 2009;253(1721):32–4.PubMed
67.
go back to reference Aprill C, Bogduk N. High-intensity zone: a diagnostic sign of painful lumbar disc on magnetic resonance imaging. Br J Radiol. 1992;65(773):361–9.CrossRefPubMed Aprill C, Bogduk N. High-intensity zone: a diagnostic sign of painful lumbar disc on magnetic resonance imaging. Br J Radiol. 1992;65(773):361–9.CrossRefPubMed
69.
go back to reference Paladini A, Varrassi G, Bentivegna G, Carletti S, Piroli A, Coaccioli S. Palmitoylethanolamide in the treatment of failed back surgery syndrome. Pain Res Treat. 2017;2017:1486010.PubMedPubMedCentral Paladini A, Varrassi G, Bentivegna G, Carletti S, Piroli A, Coaccioli S. Palmitoylethanolamide in the treatment of failed back surgery syndrome. Pain Res Treat. 2017;2017:1486010.PubMedPubMedCentral
70.
go back to reference Koc Z, Ozcakir S, Sivrioglu K, Gurbet A, Kucukoglu S. Effectiveness of physical therapy and epidural steroid injections in lumbar spinal stenosis. Spine. 2009;34(10):985–9.PubMedCrossRef Koc Z, Ozcakir S, Sivrioglu K, Gurbet A, Kucukoglu S. Effectiveness of physical therapy and epidural steroid injections in lumbar spinal stenosis. Spine. 2009;34(10):985–9.PubMedCrossRef
71.
go back to reference Foley BS, Buschbacher RM. Sacroiliac joint pain: anatomy, biomechanics, diagnosis, and treatment. Am J Phys Med Rehabil. 2006;85(12):997–1006.PubMedCrossRef Foley BS, Buschbacher RM. Sacroiliac joint pain: anatomy, biomechanics, diagnosis, and treatment. Am J Phys Med Rehabil. 2006;85(12):997–1006.PubMedCrossRef
72.
73.
go back to reference Koes BW, Backes D, Bindels PJE. Pharmacotherapy for chronic non-specific low back pain: current and future options. Exp Opin Pharmacother. 2018;19(6):537–45.CrossRef Koes BW, Backes D, Bindels PJE. Pharmacotherapy for chronic non-specific low back pain: current and future options. Exp Opin Pharmacother. 2018;19(6):537–45.CrossRef
74.
go back to reference O'Sullivan K, O'Keeffe M, O'Sullivan P. NICE low back pain guidelines: opportunities and obstacles to change practice. Br J Sports Med. 2017;51(22):1632–3.PubMedCrossRef O'Sullivan K, O'Keeffe M, O'Sullivan P. NICE low back pain guidelines: opportunities and obstacles to change practice. Br J Sports Med. 2017;51(22):1632–3.PubMedCrossRef
75.
go back to reference Gofeld M, Jitendra J, Faclier G. Radiofrequency denervation of the lumbar zygapophysial joints: 10-year prospective clinical audit. Pain Physician. 2007;10(2):291–300.PubMed Gofeld M, Jitendra J, Faclier G. Radiofrequency denervation of the lumbar zygapophysial joints: 10-year prospective clinical audit. Pain Physician. 2007;10(2):291–300.PubMed
76.
go back to reference Alhouayek M, Muccioli GG. Harnessing the anti-inflammatory potential of palmitoylethanolamide. Drug Discov Today. 2014;19(10):1632–9.PubMedCrossRef Alhouayek M, Muccioli GG. Harnessing the anti-inflammatory potential of palmitoylethanolamide. Drug Discov Today. 2014;19(10):1632–9.PubMedCrossRef
77.
go back to reference Bettoni I, Comelli F, Colombo A, Bonfanti P, Costa B. Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide. CNS Neurol Disord Drug Targets. 2013;12(1):34–44.PubMedCrossRef Bettoni I, Comelli F, Colombo A, Bonfanti P, Costa B. Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide. CNS Neurol Disord Drug Targets. 2013;12(1):34–44.PubMedCrossRef
78.
go back to reference Varrassi G, Muller-Schwefe GH. The international CHANGE PAIN physician survey: does specialism influence the perception of pain and its treatment? Curr Med Res Opin. 2012;28(5):823–31.PubMedCrossRef Varrassi G, Muller-Schwefe GH. The international CHANGE PAIN physician survey: does specialism influence the perception of pain and its treatment? Curr Med Res Opin. 2012;28(5):823–31.PubMedCrossRef
79.
go back to reference Fusco M, Paladini A, Skaper S, Varrassi G. Chronic and neuropathic pain syndrome in the elderly: pathophysiological basis and perspectives for a rational therapy. Pain Nurs Mag. 2014;3:94–104. Fusco M, Paladini A, Skaper S, Varrassi G. Chronic and neuropathic pain syndrome in the elderly: pathophysiological basis and perspectives for a rational therapy. Pain Nurs Mag. 2014;3:94–104.
81.
go back to reference Benedetti F, Arduino C, Costa S, Vighetti S, Tarenzi L, Rainero I, et al. Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective. Pain. 2006;121(1–2):133–44.PubMedCrossRef Benedetti F, Arduino C, Costa S, Vighetti S, Tarenzi L, Rainero I, et al. Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective. Pain. 2006;121(1–2):133–44.PubMedCrossRef
82.
go back to reference Banks WA. Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier. Adv Drug Deliv Rev. 2012;64(7):629–39.PubMedCrossRef Banks WA. Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier. Adv Drug Deliv Rev. 2012;64(7):629–39.PubMedCrossRef
83.
go back to reference Varrassi G, Hanna M, Macheras G, et al. Multimodal analgesia in moderate-to-severe pain: a role for a new fixed combination of dexketoprofen and tramadol. Curr Med Res Opin. 2017;33:1165–73.PubMedCrossRef Varrassi G, Hanna M, Macheras G, et al. Multimodal analgesia in moderate-to-severe pain: a role for a new fixed combination of dexketoprofen and tramadol. Curr Med Res Opin. 2017;33:1165–73.PubMedCrossRef
Metadata
Title
Pathophysiologic Approach to Pain Therapy for Complex Pain Entities: A Narrative Review
Authors
Martina Rekatsina
Antonella Paladini
Alba Piroli
Panagiotis Zis
Joseph V. Pergolizzi
Giustino Varrassi
Publication date
01-06-2020
Publisher
Springer Healthcare
Published in
Pain and Therapy / Issue 1/2020
Print ISSN: 2193-8237
Electronic ISSN: 2193-651X
DOI
https://doi.org/10.1007/s40122-019-00147-2

Other articles of this Issue 1/2020

Pain and Therapy 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.